English | Español

Regeneron Pharmaceuticals, Inc.
Press release submission | Jan 2, 2021

REGENERON: Announces Encouraging Initial Data from COVID-19 Antibody Cocktail Trial in Hospitalized Patients on Low-flow Oxygen
Press release submission | Jul 5, 2020

Regeneron and Sanofi Provide Update on Kevzara® (sarilumab) Phase 3 U.S. Trial in COVID-19 Patients
Ruth de Jauregui | May 7, 2017

Survey finds majority of rheumatoid arthritis patients living in pain

Trending
+ Pharmaceuticals
Patient Daily | Feb 19, 2025

American Lung Association hosts Fight For Air Climb in Los Angeles
+ Pharmaceuticals
Patient Daily | Feb 18, 2025

South Florida firefighter aims to defeat lung disease through annual stair climb
+ Pharmaceuticals
Patient Daily | Feb 18, 2025

Expert tips for managing springtime allergies effectively
+ Regulatory
Patient Daily | Feb 14, 2025

Spokesperson for Patients Come First: 340B program is ‘one of the most blatant abuses of a governmental program’